Sagimet, NASH liver disease drug developer, sets terms for $75M IPO (Pending:SGMT)
Chunumunu Sagimet Biosciences (SGMT), which has been growing therapies for liver illnesses reminiscent of NASH, has ...
Read more
Tag: drug
Sandoz launches rival version of AbbVie’s arthritis drug Humira By Reuters
2/2 © Reuters. FILE PHOTO: The brand of Swiss drugmaker Novartis and its divisions Sandoz and ...
Read more
Hear how Cambrian BioPharma is reinventing drug (and drug company) development
I’m thrilled to announce this TechCrunch Stay occasion. The startup Cambrian BioPharma is creating a life-changing ...
Read more